As of 2025-05-21, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 9.6x | 7.8x |
| Forward P/E multiples | 10.5x - 13.6x | 11.7x |
| Fair Price | (11.91) - (11.21) | (11.29) |
| Upside | -634.0% - -602.7% | -606.4% |
| Date | EV/EBITDA |